Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients

OBJECTIVE: Heart transplants (HTs) from hepatitis C virus (HCV)-viremic donors to HCV-seronegative recipients (HCV D+/R–) have good 6-month outcomes, but practice uptake and long-term outcomes overall and among candidates on mechanical circulatory support (MCS) have yet to be established. METHODS: U...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruck, Jessica M., Zhou, Alice L., Zeiser, Laura B., Alejo, Diane, Durand, Christine M., Massie, Allan B., Segev, Dorry L., Bush, Errol L., Kilic, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Adult: Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801334/
https://www.ncbi.nlm.nih.gov/pubmed/36590744
http://dx.doi.org/10.1016/j.xjon.2022.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801334/
https://www.ncbi.nlm.nih.gov/pubmed/36590744
http://dx.doi.org/10.1016/j.xjon.2022.10.007

Ejemplares similares